Lawrence Pemble
Direttore operativo presso CannBioRex Pharmaceuticals Corp.
Posizioni attive di Lawrence Pemble
Società | Posizione | Inizio | Fine |
---|---|---|---|
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | 01/04/2018 | - |
Direttore operativo | 01/05/2018 | - | |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | - | - |
Direttore operativo | - | - | |
African Cannabis Corp.
African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Direttore operativo | - | - |
Storia della carriera di Lawrence Pemble
Precedenti posizioni note di Lawrence Pemble
Società | Posizione | Inizio | Fine |
---|---|---|---|
AUSCAN RESOURCES INC. | Direttore/Membro del Consiglio | 04/12/2017 | 09/11/2021 |
Amministratore Delegato | 10/10/2018 | 05/06/2019 | |
Direttore operativo | 04/12/2017 | 05/06/2019 | |
Direttore Finanziario/CFO | 04/12/2017 | 05/06/2019 | |
Segretario Aziendale | 04/12/2017 | 05/06/2019 | |
GLOBAL GAMING TECHNOLOGIES CORP. | Direttore/Membro del Consiglio | 18/04/2019 | 15/08/2019 |
HEMOGENYX PHARMACEUTICALS PLC | Direttore/Membro del Consiglio | 01/10/2017 | 05/11/2018 |
Direttore operativo | 01/10/2017 | 05/11/2018 | |
GRAY FOX PETROLEUM CORP | Direttore/Membro del Consiglio | 31/05/2013 | 02/04/2015 |
Amministratore Delegato | 31/05/2013 | 02/04/2015 | |
Direttore Finanziario/CFO | 31/05/2013 | 29/05/2014 | |
Presidente | 31/05/2013 | 02/04/2015 | |
Segretario Aziendale | 31/05/2013 | 02/04/2015 | |
Treasurer | 31/05/2013 | 02/04/2015 | |
180 LIFE SCIENCES CORP. | Direttore operativo | - | - |
Statistiche
Distribuzione geografica
Canada | 6 |
Stati Uniti | 3 |
Regno Unito | 2 |
Posizioni
Director/Board Member | 6 |
Chief Operating Officer | 6 |
Chief Executive Officer | 2 |
Settori
Health Technology | 5 |
Finance | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 4 |
---|---|
GLOBAL GAMING TECHNOLOGIES CORP. | Finance |
HEMOGENYX PHARMACEUTICALS PLC | Health Technology |
AUSCAN RESOURCES INC. | Process Industries |
180 LIFE SCIENCES CORP. | Health Technology |
Aziende private | 4 |
---|---|
Grey Fox Holdings Corp.
Grey Fox Holdings Corp. RestaurantsConsumer Services Grey Fox Holdings Corp. was engaged in the acquisition of revenue generating subsidiaries to increase company revenues and shareholder value. The company was founded by Viatcheslav Gelshteyn on September 22, 2011 and was headquartered in Longwood, FL. | Consumer Services |
CannBioRex Pharmaceuticals Corp.
CannBioRex Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology CannBioRex Pharmaceuticals Corp. is a research company that specializes in the clinical development of synthetic pharmaceutical grade cannabinoid compounds for the treatment in rheumatoid arthritis and related arthritic diseases. It also plans to develop novel orally available and patentable medications to treat arthritis, multiple sclerosis, diabetes, psoriasis, obesity and fatty liver, and various painful conditions. The company was founded by Marc Feldmann and Raphael Mechoulam on March 8, 2018 and is headquartered in Toronto, Canada. | Health Technology |
African Cannabis Corp.
African Cannabis Corp. Medical/Nursing ServicesHealth Services African Cannabis Corp. engages in providing cannabis products. It offers dried cannabis flower and cannabis oil products for medical uses. The firm's cannabis are used for the treatment of anxiety/stress disorders, metabolic disorders/diabetes, neuro inflammation, neurological disorders/epilepsy, oxidative injury, nausea and schizophrenia. The company was founded by Kojo Annan and Carl Esprey in 2018 and is headquartered in Toronto, Canada. | Health Services |
Katexco Pharmaceuticals Corp.
Katexco Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Katexco Pharmaceuticals Corp. operates as medical marijuana company that engages in the development of orally available therapies harnessing endocannabinoid and nicotine receptors to treat inflammatory diseases. The company was founded by Jonathan Rothbard, Lawrence Steinman and Marc Feldmann and is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Lawrence Pemble
- Esperienza